These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 34441381)
1. Hypercoagulable State in COPD-A Comprehensive Literature Review. Kyriakopoulos C; Gogali A; Kostikas K; Konstantinidis A Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441381 [TBL] [Abstract][Full Text] [Related]
2. Acute exacerbations of COPD are associated with a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation. van der Vorm LN; Li L; Huskens D; Hulstein JJJ; Roest M; de Groot PG; Ten Cate H; de Laat B; Remijn JA; Simons SO Respir Med; 2020 Sep; 171():106094. PubMed ID: 32758992 [TBL] [Abstract][Full Text] [Related]
3. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Tapson VF Proc Am Thorac Soc; 2005; 2(1):71-7. PubMed ID: 16113472 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD. Ambrosetti M; Ageno W; Spanevello A; Salerno M; Pedretti RF Thromb Res; 2003; 112(4):203-7. PubMed ID: 14987912 [TBL] [Abstract][Full Text] [Related]
6. The neutrophil-to-lymphocyte ratio as a marker of chronic obstructive pulmonary disease and its exacerbations: A systematic review and meta-analysis. Paliogiannis P; Fois AG; Sotgia S; Mangoni AA; Zinellu E; Pirina P; Carru C; Zinellu A Eur J Clin Invest; 2018 Aug; 48(8):e12984. PubMed ID: 29924383 [TBL] [Abstract][Full Text] [Related]
7. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature. Doll H; Miravitlles M Pharmacoeconomics; 2005; 23(4):345-63. PubMed ID: 15853435 [TBL] [Abstract][Full Text] [Related]
8. Thoracic Imaging at Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review. Rangelov BA; Young AL; Jacob J; Cahn AP; Lee S; Wilson FJ; Hawkes DJ; Hurst JR Int J Chron Obstruct Pulmon Dis; 2020; 15():1751-1787. PubMed ID: 32801677 [TBL] [Abstract][Full Text] [Related]
9. Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD. Reilev M; Pottegård A; Lykkegaard J; Søndergaard J; Ingebrigtsen TS; Hallas J Respirology; 2019 Dec; 24(12):1183-1190. PubMed ID: 31222861 [TBL] [Abstract][Full Text] [Related]
10. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients]. Jiang M; Ma JF Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002 [TBL] [Abstract][Full Text] [Related]
11. Association between features of COPD and risk of venous thromboembolism. Dong W; Zhu Y; Du Y; Ma S Clin Respir J; 2019 Aug; 13(8):499-504. PubMed ID: 31172658 [TBL] [Abstract][Full Text] [Related]
13. Seasonal and Regional Variations in Chronic Obstructive Pulmonary Disease Exacerbation Rates in Adults without Cardiovascular Risk Factors. So JY; Zhao H; Voelker H; Reed RM; Sin D; Marchetti N; Criner GJ Ann Am Thorac Soc; 2018 Nov; 15(11):1296-1303. PubMed ID: 30063372 [TBL] [Abstract][Full Text] [Related]
14. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821 [TBL] [Abstract][Full Text] [Related]
15. Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease. Jones PW Ther Adv Respir Dis; 2015 Jun; 9(3):84-96. PubMed ID: 25801643 [TBL] [Abstract][Full Text] [Related]
16. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease. Diederen BM; van der Valk PD; Kluytmans JA; Peeters MF; Hendrix R Eur Respir J; 2007 Aug; 30(2):240-4. PubMed ID: 17459899 [TBL] [Abstract][Full Text] [Related]
17. Patient-reported Outcomes for the Detection, Quantification, and Evaluation of Chronic Obstructive Pulmonary Disease Exacerbations. Mackay AJ; Kostikas K; Murray L; Martinez FJ; Miravitlles M; Donaldson G; Banerji D; Patalano F; Wedzicha JA Am J Respir Crit Care Med; 2018 Sep; 198(6):730-738. PubMed ID: 29671615 [TBL] [Abstract][Full Text] [Related]
18. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients. Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858 [TBL] [Abstract][Full Text] [Related]
19. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study. Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794 [TBL] [Abstract][Full Text] [Related]
20. Stability of Frequency of Severe Chronic Obstructive Pulmonary Disease Exacerbations and Health Care Utilization in Clinical Populations. Blagev DP; Collingridge DS; Rea S; Press VG; Churpek MM; Carey K; Mularski RA; Zeng S; Arjomandi M Chronic Obstr Pulm Dis; 2018 Jun; 5(3):208-220. PubMed ID: 30584584 [No Abstract] [Full Text] [Related] [Next] [New Search]